Azilsartan medoxomil, belimumab, and lurasidone hydrochloride

Journal of the American Pharmacists Association

Volumn 51, Issue 3, 2011, Pages 444-447

  Hussar, Daniel A ^a,b   Shah, Anokhi ^b  

^a Department of Pharmacy ^*  (United States)

^b UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZILSARTAN MEDOXOMIL; BELIMUMAB; LURASIDONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; ISOINDOLE DERIVATIVE; MONOCLONAL ANTIBODY; N (2 (4 (1,2 BENZISOTHIAZOL 3 YL) 1 PIPERAZINYLMETHYL) 1 CYCLOHEXYLMETHYL) 2,3 BICYCLO(2.2.1)HEPTANEDICARBOXIMIDE; N-(2-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYLMETHYL)-1-CYCLOHEXYLMETHYL)-2,3-BICYCLO(2.2.1)HEPTANEDICARBOXIMIDE; NEUROLEPTIC AGENT; OXADIAZOLE DERIVATIVE; THIAZOLE DERIVATIVE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CONTRACEPTION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; HYPERTENSION; PREGNANCY; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; ARTICLE; HUMAN; SCHIZOPHRENIA;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIBODIES, MONOCLONAL; ANTIPSYCHOTIC AGENTS; BENZIMIDAZOLES; HUMANS; HYPERTENSION; ISOINDOLES; LUPUS ERYTHEMATOSUS, SYSTEMIC; OXADIAZOLES; SCHIZOPHRENIA; THIAZOLES;

EID: 84855544163     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2011.11522     Document Type: Article

References (0)